Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-055357
Filing Date
2025-04-17
Accepted
2025-04-17 16:01:15
Documents
19
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A allk-20241231.htm   iXBRL 10-K/A 1567257
2 EX-31.3 allk-ex31_3.htm EX-31.3 10215
3 EX-31.4 allk-ex31_4.htm EX-31.4 10147
4 GRAPHIC img121138370_0.jpg GRAPHIC 54918
5 GRAPHIC img121138370_1.jpg GRAPHIC 55259
6 GRAPHIC img121138370_2.jpg GRAPHIC 424206
7 GRAPHIC img121138370_3.jpg GRAPHIC 446175
  Complete submission text file 0000950170-25-055357.txt   4724146

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20241231.xsd EX-101.SCH 52183
22 EXTRACTED XBRL INSTANCE DOCUMENT allk-20241231_htm.xml XML 184668
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38582 | Film No.: 25847175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)